Discontinued — last reported Q3 '19
Non-Current Liabilities
Operating Lease Liabilities
Vertex Pharmaceuticals Operating Lease Liabilities increased by 0.6% to $1.85B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.6%, from $1.54B to $1.85B. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities shows an upward trend with a 39.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ3 2019
How to read this metric
An increase reflects long-term expansion of the leased asset base, while a decrease indicates a reduction in long-term lease commitments.
Detailed definition
This represents the portion of operating lease obligations that are due beyond the next twelve months. It reflects the l...
Peer comparison
Standard long-term liability for companies with significant real estate or equipment footprints.
Metric ID:
operating_lease_liabilities_non_currentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $368.92M | $363.55M | $377.40M | $377.00M | $365.00M | $382.30M | $379.50M | $371.60M | $363.50M | $354.40M | $348.60M | $359.80M | $586.80M | $1.59B | $1.54B | $1.54B | $1.53B | $1.83B | $1.85B |
| QoQ Change | — | -1.5% | +3.8% | -0.1% | -3.2% | +4.7% | -0.7% | -2.1% | -2.2% | -2.5% | -1.6% | +3.2% | +63.1% | +170.8% | -2.8% | -0.4% | -0.7% | +20.1% | +0.6% |
| YoY Change | — | — | — | — | -1.1% | +5.2% | +0.6% | -1.4% | -0.4% | -7.3% | -8.1% | -3.2% | +61.4% | +348.3% | +343.0% | +327.4% | +160.3% | +15.5% | +19.6% |
Range$348.60M – $1.85B
CAGR+43.0%
Avg YoY Growth+84.0%
Median YoY Growth+5.2%
Current Streak2 quarters growth
Operating Lease Liabilities at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating lease liabilities?
- Vertex Pharmaceuticals (VRTX) reported operating lease liabilities of $1.85B in Q4 2025.
- How has Vertex Pharmaceuticals's operating lease liabilities changed year-over-year?
- Vertex Pharmaceuticals's operating lease liabilities increased by 19.6% year-over-year, from $1.54B to $1.85B.
- What is the long-term trend for Vertex Pharmaceuticals's operating lease liabilities?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's operating lease liabilities has grown at a 39.4% compound annual growth rate (CAGR), from $350.46M to $1.85B.
- What does operating lease liabilities mean?
- The amount of lease payments due after one year.